Beech Tree Labs specializes in discovery and early-stage development of therapeutic agents for chronic disorders. Product candidates may be out-licensed at any time from mechanism-of-action studies through proof-of-concept, FDA-authorized clinical trials.
Beech Tree has several product candidates in various stages of development and a robust pipeline. Lead product candidates are those addressing scars and adhesions such as occurring from total knee replacement surgery and COPD, an anti-viral targeting herpesvirus infection, and a formulation addressing muscle weakness disorders such as urinary incontinence. For more information, please see Therapies.